These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 34477047)
21. Fangchinoline exerts antitumour activity by suppressing the EGFR‑PI3K/AKT signalling pathway in colon adenocarcinoma. Jiang F; Ren S; Chen Y; Zhang A; Zhu Y; Zhang Z; Li Z; Piao D Oncol Rep; 2021 Jan; 45(1):139-150. PubMed ID: 33416119 [TBL] [Abstract][Full Text] [Related]
22. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway. Chen JM; Bai JY; Yang KX IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742 [TBL] [Abstract][Full Text] [Related]
23. LINC00342 regulates cell proliferation, apoptosis, migration and invasion in colon adenocarcinoma via miR-545-5p/MDM2 axis. Miao Z; Liu S; Xiao X; Li D Gene; 2020 Jun; 743():144604. PubMed ID: 32213297 [TBL] [Abstract][Full Text] [Related]
24. KLF7 promotes colon adenocarcinoma progression through the PDGFB signaling pathway. Zhang Z; Jiang X; Li K; Qiao S; Li M; Mei Y; Ding L; Lv Q; Ding Y; Zhao Y; Lv G; Tan G; Yang H; Li G; Gao X; Liu M Int J Biol Sci; 2024; 20(1):387-402. PubMed ID: 38164176 [TBL] [Abstract][Full Text] [Related]
25. Comprehensive Analysis Identifies PI3K/Akt Pathway Alternations as an Immune-Related Prognostic Biomarker in Colon Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitor Treatment. Lin A; Gu T; Hu X; Zhang J; Luo P J Immunol Res; 2022; 2022():8179799. PubMed ID: 35707003 [TBL] [Abstract][Full Text] [Related]
26. The tyrosine phosphatase SHP2 promotes proliferation and oxaliplatin resistance of colon cancer cells through AKT and ERK. Yu M; Xu C; Zhang H; Lun J; Wang L; Zhang G; Fang J Biochem Biophys Res Commun; 2021 Jul; 563():1-7. PubMed ID: 34052504 [TBL] [Abstract][Full Text] [Related]
27. RecQ protein-like 4 drives cisplatin chemosensitivity of cervical cancer cells by modulating annexin A2. Wang R; Zhang Y Drug Dev Res; 2024 Nov; 85(7):e70003. PubMed ID: 39404003 [TBL] [Abstract][Full Text] [Related]
28. Prediction and verification of targets for α-hederin/oxaliplatin dual-loaded rHDL modified liposomes: Reversing effector T-cells dysfunction and improving anti-COAD efficiency in vitro and in vivo. Wang G; Xu XN; Zhi-Min Z; Wang K; Li F Int J Pharm; 2024 Sep; 662():124512. PubMed ID: 39067547 [TBL] [Abstract][Full Text] [Related]
29. Cisplatin resistance in lung cancer is mediated by MACC1 expression through PI3K/AKT signaling pathway activation. Zhang Q; Zhang B; Sun L; Yan Q; Zhang Y; Zhang Z; Su Y; Wang C Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):748-756. PubMed ID: 29961813 [TBL] [Abstract][Full Text] [Related]
30. LEM domain containing 1 (LEMD1) transcriptionally activated by SRY-related high-mobility-group box 4 (SOX4) accelerates the progression of colon cancer by upregulating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway. Li D; Wang D; Liu H; Jiang X Bioengineered; 2022 Apr; 13(4):8087-8100. PubMed ID: 35294319 [TBL] [Abstract][Full Text] [Related]
31. Oxaliplatin inhibits colorectal cancer progression by inhibiting CXCL11 secreted by cancer-associated fibroblasts and the CXCR3/PI3K/AKT pathway. Lu C; Zhang C Clin Transl Oncol; 2023 Jan; 25(1):160-172. PubMed ID: 36129606 [TBL] [Abstract][Full Text] [Related]
32. CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-κB signaling pathway. Shen T; Yang Z; Cheng X; Xiao Y; Yu K; Cai X; Xia C; Li Y Oncol Rep; 2017 Apr; 37(4):2095-2100. PubMed ID: 28259918 [TBL] [Abstract][Full Text] [Related]
33. A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer. Zhang F; Li K; Yao X; Wang H; Li W; Wu J; Li M; Zhou R; Xu L; Zhao L EBioMedicine; 2019 Jun; 44():311-321. PubMed ID: 31078520 [TBL] [Abstract][Full Text] [Related]
34. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway. Xu J; Zhang S; Wang R; Wu X; Zeng L; Fu Z Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28432271 [TBL] [Abstract][Full Text] [Related]
35. HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties. Xu Y; Jiang Z; Zhang Z; Sun N; Zhang M; Xie J; Li T; Hou Y; Wu D J Cell Biochem; 2014 Jun; 115(6):1112-21. PubMed ID: 24356998 [TBL] [Abstract][Full Text] [Related]
36. Upregulation of CD44v6 contributes to acquired chemoresistance via the modulation of autophagy in colon cancer SW480 cells. Lv L; Liu HG; Dong SY; Yang F; Wang QX; Guo GL; Pan YF; Zhang XH Tumour Biol; 2016 Jul; 37(7):8811-24. PubMed ID: 26747179 [TBL] [Abstract][Full Text] [Related]
37. Fraxetin inhibits the growth of colon adenocarcinoma cells via the Janus kinase 2/signal transducer and activator of transcription 3 signalling pathway. Ren S; Xing Y; Wang C; Jiang F; Liu G; Li Z; Jiang T; Zhu Y; Piao D Int J Biochem Cell Biol; 2020 Aug; 125():105777. PubMed ID: 32504672 [TBL] [Abstract][Full Text] [Related]
38. PSAT1 Upregulation Contributes to Cell Growth and Cisplatin Resistance in Cervical Cancer Cells via Regulating PI3K/AKT Signaling Pathway. Duan W; Liu X Ann Clin Lab Sci; 2020 Jul; 50(4):512-518. PubMed ID: 32826249 [TBL] [Abstract][Full Text] [Related]
39. Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents. Mao M; Tian F; Mariadason JM; Tsao CC; Lemos R; Dayyani F; Gopal YN; Jiang ZQ; Wistuba II; Tang XM; Bornman WG; Bollag G; Mills GB; Powis G; Desai J; Gallick GE; Davies MA; Kopetz S Clin Cancer Res; 2013 Feb; 19(3):657-67. PubMed ID: 23251002 [TBL] [Abstract][Full Text] [Related]
40. Acid ceramidase inhibition sensitizes human colon cancer cells to oxaliplatin through downregulation of transglutaminase 2 and β1 integrin/FAK-mediated signalling. Klobučar M; Grbčić P; Pavelić SK; Jonjić N; Visentin S; Sedić M Biochem Biophys Res Commun; 2018 Sep; 503(2):843-848. PubMed ID: 29920241 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]